![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1873-4286|20|41|6422-6437
ISSN: 1381-6128
Source: Current Pharmaceutical Design, Vol.20, Iss.41, 2014-12, pp. : 6422-6437
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
The Design of G-quadruplex Ligands as Telomerase Inhibitors
Mini Reviews in Medicinal Chemistry, Vol. 3, Iss. 1, 2003-02 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Cell Cycle Regulation of G-Quadruplex DNA Structures at Telomeres
Current Pharmaceutical Design, Vol. 18, Iss. 14, 2012-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
RNA G-Quadruplex: The New Potential Targets for Therapy
Current Topics in Medicinal Chemistry, Vol. 15, Iss. 19, 2015-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Telomeres and telomerase: targets for cancer chemotherapy?
Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 12, 1998-12 ,pp. :